JBS (JBS) Stock Price & Analysis
JBS (JBS) fell 0.84% to USD 13.03 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
JBS last closed at USD 13.14; the session ranged USD 12.87–13.41 on volume of 4,615,528 shares. Market capitalization is $13.95B, with a 52-week range of USD 11.49–18.65 (NYQ). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 13.03 |
|---|---|
| Change | ▼ 0.84% (down) |
| Previous Close | USD 13.14 |
| Open | USD 13.07 |
| Day Range | USD 12.87 – 13.41 |
| 52-Week Range | USD 11.49 – 18.65 |
| Volume | 4,615,528 shares |
| Market Cap | $13.95B |
| Exchange | NYQ |
Technical Analysis (JBS)
Nexqual's technical model rates JBS "NEUTRAL" based on 3 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.94 (neutral) |
| vs SMA50 | Above (USD 13) |
| MACD | 0.03 (positive) |
Analyst Ratings (JBS)
Wall Street analysts rate JBS "Buy" based on 14 analysts, with a mean price target of USD 18.28 (range USD 15.11–20.87), per Nexqual as of September 8, 2026 at 07:34 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 18.28 |
| High Target | USD 20.87 |
| Low Target | USD 15.11 |
| Buy / Hold / Sell | 12 / 2 / 0 |
Earnings (JBS)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 1.63 |
| Revenue Estimate | $122.38B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.02 vs est 1.66 ▼ miss |
| 2025-12-31 | USD 3.07 vs est 2.25 ▲ beat |
| 2025-09-30 | USD 2.87 vs est 2.74 ▲ beat |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financials & Fundamentals (JBS)
| Total Revenue | $91.17B |
|---|---|
| Revenue Growth (YoY) | +13.80% |
| Gross Margin | +11.80% |
| Operating Margin | +3.07% |
| Profit Margin | +1.22% |
| ROE | +13.38% |
| Debt / Equity | 283.04 |
| Current Ratio | 1.53 |
| Total Cash | $3.47B |
| Total Debt | $25.64B |
| Free Cash Flow | $822.60M |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Financial Health Score (JBS)
Nexqual rates JBS's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 07:34 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 12%, operating 3% |
| Balance Sheet | Weak — $3.47B cash vs $25.6B debt |
| Cash Flow | Mixed — FCF $823M, slim 0.2% margin |
| Efficiency | Mixed — ROE 13%, ROA 4.9% |
Ownership (JBS)
| Insider Ownership | +57.75% |
|---|---|
| Institutional Ownership | +28.66% |
| Shares Outstanding | 776.07M |
| Float | 327.74M |
| Short % of Float | +15.86% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Leadership (JBS)
JBS is led by Gilberto Tomazoni (age 66), Global Chief Executive Officer & Executive Director, per Nexqual as of September 8, 2026 at 07:34 UTC.
| Global Chief Executive Officer & Executive Director | Gilberto Tomazoni (age 66) |
|---|---|
| Global CFO & Investor Relations Officer | Guilherme Perboyre Cavalcanti (age 57) |
| Managing & Controlling Officer, Director of Administrative & Control and Member of the Exe. Board | Eliseo Santiago Perez Fernandez (age 60) |
| Head of HR in North America & Global HR Director | Juriana Sperandio Domingues |
Major Backers & Investors (JBS)
Notable institutional backers of JBS include Bndes Participacoes S.A., Davis Selected Advisers, Shaw D.E. & Co., Inc., according to Nexqual as of September 8, 2026 at 07:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bndes Participacoes S.A. | 25.68% |
| Davis Selected Advisers | 6.44% |
| Shaw D.E. & Co., Inc. | 1.45% |
| DAVIS NEW YORK VENTURE FUND INC-Davis New York Venture Fund | 1.22% |
| Brandes Investment Partners L.P. | 0.99% |
| Ameriprise Financial, Inc. | 0.86% |
| Arrowstreet Capital, Limited Partnership | 0.78% |
| Alberta Investment Management Corp | 0.76% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 5.6% |
| State Street | 1.03% |
Source: Nexqual, September 8, 2026 at 07:34 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMRZ | Amrize Ltd | USD 43.82 | ▲ 1.98% |
| SFD | Smithfield Foods, Inc. | USD 21.97 | ▼ 1.92% |
| PRMB | Primo Brands Corporation | USD 22 | ▼ 0.23% |
| QXO | QXO, Inc. | USD 13.35 | ▲ 0.98% |
| STUB | StubHub Holdings, Inc. | USD 6.6 | ▲ 6.8% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.